Query: Products of Medimmune, Inc.

Relevant passages:
Abrilumab <=SEP=> Abrilumab is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.This drug was developed by MedImmune.

Altvater v. Freeman <=SEP=> Altvater v. Freeman, 319 U.S. 359 (1943), was a decision by the Supreme Court of the United States which held that, although a licensee had maintained payments of royalties, a Declaratory Judgment Act claim of invalidity of the licensed patent still presented a justiciable case or controversy.

Amifostine <=SEP=> Amifostine is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by MedImmune under the trade name Ethyol.

Anifrolumab <=SEP=> Anifrolumab is a monoclonal antibody designed for the treatment of systemic lupus erythematosus.This drug was developed by MedImmune.

Arm & Hammer <=SEP=> Arm & Hammer is a registered trademark of Church & Dwight, an American manufacturer of household products.  The logo of this brand is a muscular arm holding a hammer. Originally associated only with baking soda and washing soda, the company began to expand the brand to other products in the 1970s using baking soda as a deodorizing ingredient, including toothpaste, laundry detergent, underarm deodorant, and cat litter.

AstraZeneca <=SEP=> AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom.

Beatrice Foods <=SEP=> Beatrice Foods Company was a major American food processing company. In 1987, its smaller international food operations were sold to Reginald Lewis, a corporate attorney, creating TLC Beatrice International, after which the majority of its domestic (U.S.) brands and assets were acquired by Kohlberg, Kravis, Roberts (KKR), with the bulk of its holdings sold off. By 1990, the remaining operations were ultimately acquired by ConAgra Foods.

Benralizumab <=SEP=> Benralizumab (INN) is a monoclonal antibody which is being developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).

Biotechnology <=SEP=> Biotechnology is the use of living systems and organisms to develop or make products, or "any technological application that uses biological systems, living organisms or derivatives thereof, to make or modify products or processes for specific use" (UN Convention on Biological Diversity, Art. 2).

Bombardier Transportation <=SEP=> Bombardier Transportation is the rail equipment division of the Canadian firm Bombardier Inc. Bombardier Transportation is one of the world's largest companies in the rail vehicle and equipment manufacturing and servicing industry.  The division is headquartered in Berlin, Germany with regional offices and major development facilities in Canada (Montreal, Quebec & Toronto, Ontario) and the United States (Plattsburgh, New York).

Boston Patent Law Association <=SEP=> Founded in Boston in 1924, the Boston Patent Law Association (BPLA) is an organization of intellectual property professionals that has a membership of over 1000 individuals.  Primarily located in the jurisdiction of the United States Court of Appeals for the First Circuit, the BPLA’s members are a diverse population of attorneys and other professionals in the field of  intellectual property law, encompassing trademark, patent, and copyright laws.

Brown Company <=SEP=> The Brown Company, also known as the Brown Corporation, was a pulp and papermaking company based in Berlin, New Hampshire, United States. They closed their doors during the 1980s.

Cabilly patents <=SEP=> The Cabilly patents are two US patents issued to Genentech and City of Hope which relate to the "fundamental technology required for the artificial synthesis of antibody molecules."  The name refers to lead inventor Shmuel Cabilly, who was awarded the patent while working at City of Hope in the 1980s. There was ongoing legal controversy surrounding these patents since their original filing in 1983.  In 2008, the litigation that was pending before the U.S.

Cambridge Antibody Technology <=SEP=> Cambridge Antibody Technology (officially Cambridge Antibody Technology Group Plc, informally CAT) was a biotechnology company headquartered in Cambridge, England, United Kingdom. Its core focus was on antibody therapeutics, primarily using phage display and ribosome display technology.Technology developed by CAT was used to create adalimumab, the first fully human antibody blockbuster drug.

Dairy Farmers of America <=SEP=> Dairy Farmers of America Inc. (DFA) is a national milk marketing cooperative in the United States. It is owned by and serves nearly 15,000 dairy farmer-members representing more than 9,000 dairy farms in 48 states.  DFA markets members' raw milk and sells milk and derivative products (dairy products, food components, ingredients and shelf-stable dairy products) to wholesale buyers.

Durvalumab <=SEP=> Durvalumab is a monoclonal antibody designed for the treatment of cancer.This drug was developed by MedImmune.

Dusigitumab <=SEP=> Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2.This drug was developed by MedImmune, LLC.

Ecover <=SEP=> Ecover is a Belgium-based company that manufactures ecologically sound cleaning products (made from plant-based and mineral ingredients).

Enokizumab <=SEP=> Enokizumab is a humanized monoclonal antibody designed for the treatment of asthma.Enokizumab was developed by MedImmune.

Etaracizumab <=SEP=> Etaracizumab (also known as etaratuzumab, MEDI-522, trade name Abegrin) is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune.

Evotec <=SEP=> Evotec AG is a drug discovery alliance and development partnership company focused on progressing product approaches with pharmaceutical and biotechnology companies.The company's headquarters are located in Hamburg, Germany. It operates worldwide providing integrated drug discovery solutions, covering all activities from target-to-clinic.Evotec employs over 500 scientists and works in key therapeutic areas including CNS/neurology (e.g.

Food and Drug Administration <=SEP=> The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.

Gaithersburg, Maryland <=SEP=> Gaithersburg (About this sound pronunciation ), officially the City of Gaithersburg, is a city located in Montgomery County, Maryland. At the time of the 2010 census, Gaithersburg had a population of 59,933, making it the fourth largest incorporated city in the state, behind Baltimore, Frederick, and Rockville.

Genentech <=SEP=> Genentech Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.As of November 2014, Genentech employed nearly 12,900 people. In July 2014, Genentech announced its acquisition of Seragon for up to $1.725 billion.

Granta Park <=SEP=> Granta Park is a science, technology and biopharmaceutical park based on the bank of the River Granta in Great Abington near Cambridge, England.The first idea for the park came from the then Chief Executive of The Welding Institute (TWI Ltd) Bevan Braithwaite OBE.

H5N1 clinical trials <=SEP=> H5N1 clinical trials are clinical trials concerning H5N1 vaccines, which are intended to provide immunization to influenza A virus subtype H5N1. They are intended to discover pharmacological effects and identify any adverse reactions the vaccines may achieve in humans.

Immunocore <=SEP=> Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops cancer treatments using T-cell receptors (TCRs).

Index of biotechnology articles <=SEP=> This page provides an alphabetical list of articles and other pages (including categories, lists, etc.) about biotechnology.  For other overviews of the topic, please see the Biotechnology portal.

John McCafferty <=SEP=> John McCafferty is a British scientist, one of the founders of Cambridge Antibody Technology, well known as one of the inventors of scFv antibody fragment phage display, a technology that revolutionised the  monoclonal antibody drug discovery.

Jonathan Ive <=SEP=> Sir Jonathan Paul Ive, KBE (born February 27, 1967) is a British designer and the Chief Design Officer (CDO) of Apple Inc. He oversees the Apple Industrial Design Group and also provides leadership and direction for Human Interface software teams across the company. Ive is the designer of many of Apple's products, including the MacBook Pro, iMac, MacBook Air, Mac mini, iPod, iPod Touch, iPhone, iPad, iPad Mini, Apple Watch and iOS.

Juno Therapeutics <=SEP=> Juno Therapeutics is a biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and a further $265 million through their IPO.

List of Bombardier recreational and snow vehicles <=SEP=> List of Bombardier recreational and snow vehicles and products. These vehicles and craft were made by Bombardier or from 2003 Bombardier Recreational Products of Canada. In 2004 the industrial vehicles division was sold to the Camoplast company of Canada. Subsequently Camoplast sold their Track Machines Division to Primoth, which is part of the Leitner Group [1].

List of United States Supreme Court cases, volume 549 <=SEP=> This is a list of all the United States Supreme Court cases from volume 549 of the United States Reports:Ayers v. Belmontes, 549 U.S. 7 (2006)Lopez v. Gonzales, 549 U.S. 47 (2006)Toledo-Flores v. United States, 549 U.S. 69 (2006)Carey v. Musladin, 549 U.S. 70 (2006)BP America Production Co. v. Burton, 549 U.S. 84 (2006)United States v. Resendiz-Ponce, 549 U.S. 102 (2007)MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007)Burton v. Stewart, 549 U.S. 147 (2007)Norfolk Southern R. Co. v.

List of United States Supreme Court patent case law <=SEP=> This is an incomplete list of Supreme Court of the United States cases in the area of patent law.

List of United States patent law cases <=SEP=> This is a list of notable patent law cases in the United States in chronological order. The cases have been decided notably by the United States Supreme Court, the United States Court of Appeals for the Federal Circuit (CAFC) or the Board of Patent Appeals and Interferences (BPAI). While the Federal Circuit (CAFC) sits below the Supreme Court in the hierarchy of U.S. federal courts, patent cases only have the right of appeal to the Federal Circuit.  The U.S.

List of biotechnology companies <=SEP=> A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery.

List of companies of the United States by state <=SEP=> This is a list of companies of the United States by state where their headquarters is located:

List of patent case law <=SEP=> This list contains an alphabetical listing of historically significant or leading case law in the area of patent law. For a list of patent law cases in just the United States, see United States patent law cases.

List of products discontinued by Apple Inc. <=SEP=> The following is a list of Apple Inc. (formerly known as Apple Computer Inc.) software and hardware products that were superseded by improved versions, or discontinued, and are no longer manufactured. The first Apple product to be discontinued was the Apple I in 1977, superseded by the Apple II. The most recently discontinued products have been several iPod models including the iPod mini, replaced by the iPod nano.

Live attenuated influenza vaccine <=SEP=> Live attenuated influenza vaccine (LAIV) is a type of influenza vaccine in the form of a nasal spray. It is an attenuated vaccine, unlike most influenza vaccines, which are inactivated vaccines. LAIV is administered intranasally, while inactivated vaccines are administered by intramuscular injection. Both live attenuated and inactivated vaccines are typically trivalent.

Mavrilimumab <=SEP=> Mavrilimumab is a human monoclonal antibody designed for the treatment of rheumatoid arthritis.Mavrilimumab was discovered as CAM-3001 by Cambridge Antibody Technology and is being developed by MedImmune, Inc.

MedImmune, Inc. v. Genentech, Inc. <=SEP=> MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007) was a decision by the Supreme Court of the United States involving patent law.  It arose from a lawsuit filed by MedImmune which challenged one of the Cabilly patents issued to Genentech. One of the central issues was whether a licensee retained the right to challenge a licensed patent, or whether this right was forfeited upon signing of the license agreement.

MedImmune <=SEP=> MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise. It produces Synagis, a drug for the prevention of respiratory infections in infants, which accounted for US$ 1.06 billion of its US$ 1.2 billion in revenue for 2005, and FluMist, a nasal spray influenza vaccine introduced in 2004.

Medtronic, Inc. v. Mirowski Family Ventures, LLC <=SEP=> Medtronic, Inc. v. Mirowski Family Ventures, LLC is a case of the Supreme Court of the United States that deals with civil procedure, and specifically with the question of the burden of proof required in pursuing declaratory judgments.

Modular product of graphs <=SEP=> In graph theory, the modular product of graphs G and H is a graph such that the vertex set of the modular product of G and H is the cartesian product V(G) ×  V(H); and any two vertices (u, v) and (u' , v' ) are adjacent in the modular product of G and H if and only if either  u is adjacent with u'  and v is adjacent with v' , or u is not adjacent with u'  and v is not adjacent with v' .Cliques in the modular product graph correspond to isomorphisms of induced subgraphs of G and H.

Motavizumab <=SEP=> Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009, it is undergoing Phase II and III clinical trials.In June 2010, the FDA Antiviral Drugs Advisory Committee declined to endorse MedImmune's request for licensure of Motavizumab in a 14 to 3 decision.

Moxetumomab pasudotox <=SEP=> Moxetumomab pasudotox is an anti-CD22 mouse monoclonal antibody designed for the treatment of cancer.Moxetumomab pasudotox is currently being developed by the biologics division of AstraZeneca, MedImmune.On 16 May 2013, the first dose in a Phase III trail was administered.

Munchkin Inc. <=SEP=> Munchkin, Inc. is a privately held, global infant and toddler company headquartered in Van Nuys, California. It was founded in 1991 by Steven B. Dunn and is known for designing, developing, manufacturing, and distributing infant and toddler products.

Palivizumab <=SEP=> Palivizumab (brand name Synagis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease. Palivizumab is a humanized monoclonal antibody (IgG) directed against an epitope in the A antigenic site of the F protein of RSV.

Pet, Inc. <=SEP=> Pet, Inc., was an American company that was the first to commercially produce evaporated milk as a shelf-stable consumer product and later became a multi-brand food products conglomerate.  Its signature product, PET Evaporated Milk, is now a product of The J.M. Smucker Company.  PET Dairy is a regional brand of fresh and processed dairy products in the Southeastern United States made by the Land-O-Sun division of Dean Foods. Many of the remaining brands once owned by Pet, Inc.

Pharmaceutical industry <=SEP=> The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals for use as medications. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.

Pharmaceutical industry in the United Kingdom <=SEP=> The pharmaceutical industry in the United Kingdom directly employs around 72,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development.

Progress Rail Services <=SEP=> Progress Rail Services Corporation, a wholly owned subsidiary of Caterpillar since 2006, is a supplier of railroad and transit system products and services headquartered in Albertville, Alabama, United States. Founded as a recycling company in 1982, Progress Rail has increased the number of its product and service offerings over time to become one of the largest integrated and diversified suppliers of railroad and transit system products and services in North America.

Remand (court procedure) <=SEP=> A remand is an action taken by an appellate court in which it sends back a case to the trial court or lower appellate court for further action.For example, if the trial judge committed a procedural error, failed to admit evidence or witnesses that the appellate court ruled should have been admitted, or ruled improperly on a litigant's motion, the appellate court may send the case back to the lower court for retrial or other action.A case is said to be "remanded" when the superior court returns or sends back the case to the lower court. @en <http://en.wikipedia.org/wiki/Remand_(court_procedure)?oldid=667599873> .
<http://dbpedia.org/resource/Ahmad_ibn_'Imad_al-Din> <http://www.w3.org/2000/01/rdf-schema#comment> Aḥmad ibn ‘Imād al-Dīn, Ahmad ibn Imad ad-Din (Arabic: أحمد بن عماد الدين‎) was a Persian physician and alchemist. He was probably from Nishapur in the 11th century.He was the author of an alchemical treatise titled On the Art of the Elixir (or Fi sina‘at al-iksir) which is preserved in the National Library of Medicine.No other copy has been identified, and the author is not listed in the published bibliographies of Islamic writers on alchemy.

Rho Ventures <=SEP=> Rho Ventures is a venture capital firm that actively invests in technology, new media, cleantech and healthcare companies.The firm, which is based in New York City, Palo Alto and Montreal, was founded in 1981.  The firm has raised over $2 billion since inception across 6 funds.  The firm is currently investing their sixth fund, Rho Ventures VI, a $510 million fund launched in 2008.Rho has invested in approximately 200 venture stage companies.

Saputo Inc. <=SEP=> Saputo Inc. (TSX: SAP) is a Montreal-based Canadian dairy company. Founded as a cheese making company in 1954 by Italian immigrant Giuseppe Saputo, today Saputo's business includes dairy products, and it is the tenth largest dairy processor in the world.  After growing in its home region of Quebec, the company has expanded by mergers and acquisitions. Saputo operates in Canada, as well as in the United States, Argentina and Australia. The Company operated in Wales and Germany from 2006 to 2013.

Sealtest Dairy <=SEP=> Sealtest Dairy was a division of National Dairy Products Corporation (predecessor to Kraft Foods, Inc.) of Delaware. It produced milk, cream, ice cream, and lemonade. The Sealtest brand was also later used by various companies in Canada under licence (now held by Agropur).

Seattle Genetics <=SEP=> Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered  monoclonal antibody-based therapies for the treatment of cancer.  The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.

Sifalimumab <=SEP=> Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.Sifalimumab was developed by MedImmune.

Solar Turbines <=SEP=> Solar Turbines Incorporated, a wholly owned subsidiary of Caterpillar Inc., designs and manufactures industrial gas turbines for on- and off-shore electrical power generation, for marine propulsion and for producing, processing and transporting natural gas and oil. Solar Turbines is one of the world's leading producers of industrial gas turbines up to 30,000 horsepower (22,000 kW).

Strong product of graphs <=SEP=> In graph theory, the strong product  G ⊠ H  of graphs G and H is a graph such that the vertex set of G ⊠ H is the Cartesian product V(G) × V(H); and any two distinct vertices (u,u') and (v,v') are adjacent in G × H if and only if: u is adjacent to v and u'=v', or u=v and u' is adjacent to v', or u is adjacent to v and u' is adjacent to v'The strong product is also called the normal product and AND product.  It was first introduced by Sabidussi in 1960.

Tech Council of Maryland <=SEP=> The Tech Council of Maryland (TCM) is a technology trade association for companies with operations in Maryland, Washington, D.C. and Virginia. TCM has two divisions: The Tech Alliance, which serves the advanced technology industry, and MdBio, which serves the Maryland biotech industry.

Timeline of Apple Inc. products <=SEP=> This timeline of Apple Inc. products is a list of all stand-alone Apple II, Macintosh, and other computers, as well as computer peripherals, expansion cards, software, ancillary products, and consumer electronics sold by Apple Inc. in order of introduction date.== Timeline of Apple Inc. products ==Products on this timeline indicate introduction dates only and not necessarily discontinued dates, as new products begin on a contiguous product line.

Tovetumab <=SEP=> Tovetumab is a monoclonal antibody designed for the treatment of cancer.This drug was developed by MedImmune, LLC.

Tralokinumab <=SEP=> Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354 and taken through pre-clinical development. As of April 2012 it is being developed by MedImmune, a member of the AstraZeneca group, where it is currently in Ph3 testing for asthma and Ph2 testing for atopic dermatitis.

Ultima Foods <=SEP=> Ultima Foods Inc. is a Canadian manufacturer and marketer of yogurt and fresh dairy products. Founded in 1993 (with predecessor operations dating to 1971), Ultima Foods is a partnership of Quebec-based dairy company Agropur and Alberta-based Agrifoods International Cooperative Ltd, and has 750 employees across the country. The company launched the iögo brand of yogurt and fresh dairy products in Canada in mid-August 2012, and also owns and operates the Olympic brand of dairy products.

Ultra Products <=SEP=> Ultra Products, a division of the Systemax group of companies, is a US-based computer parts manufacturer, importer and distributor.The company's main focus is on PC accessories, and offers a full gamut of products including computer memory, computer cases and power supplies, custom cooling solutions and uninterruptible power supplies.The company attracted attention in PC publications when they produced the first modular computer power supply, the Ultra X-Connect.The history of Ultra Products dates back to 1991 with the Fletcher, Ohio based PC builder, MidWest Micro.